|
Re: Suggestion
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 24, 2018 09:12AM
|
|
Re: Answer from IR - 250 confrimed MACE would require disclosure
|
1
|
Resverlogix Corp.
|
Jan 31, 2019 11:46AM
|
|
Re: Warrants RVX.WT.A
|
1
|
Resverlogix Corp.
|
Jun 07, 2019 10:07AM
|
|
Re: Latest on COVID-19
|
1
|
Resverlogix Corp.
|
Sep 29, 2022 09:30AM
|
|
Re: 48 hours
|
1
|
Resverlogix Corp.
|
Nov 15, 2019 01:56PM
|
|
Re: Short pos?
|
1
|
Resverlogix Corp.
|
Mar 18, 2020 06:12PM
|
|
Re: What impact would a PR like this have?
|
1
|
Resverlogix Corp.
|
Jan 29, 2019 04:21PM
|
|
Re: Contest Tally
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 12:56PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
1
|
Resverlogix Corp.
|
Jan 18, 2021 04:34PM
|
|
Re: AGM 2018 - Masila Notes
|
1
|
Resverlogix Corp.
|
Jun 13, 2019 07:27AM
|
|
Re: RESVERLOGIX CORP.CODE OF BUSINESS CONDUCT AND ETHICS
|
1
|
Resverlogix Corp.
|
Sep 12, 2019 03:36PM
|
|
Let's play a what if...
|
1
|
Resverlogix Corp.
|
Nov 27, 2019 12:46PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
1
|
Resverlogix Corp.
|
Apr 05, 2022 05:52PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
1
|
Zenith Epigenetics
|
Apr 21, 2022 06:51AM
|
|
Re: Wishing this was our news release
|
1
|
Resverlogix Corp.
|
May 27, 2022 09:58AM
|
|
Re: Warrants RVX.WT.A
|
1
|
Resverlogix Corp.
|
Jun 07, 2019 10:27AM
|
|
Re: Looking forward to the short interest update....
|
1
|
Resverlogix Corp.
|
Oct 21, 2019 08:12AM
|
|
Re: eGFR and Cognition?
|
1
|
Resverlogix Corp.
|
Nov 23, 2019 08:05AM
|
|
Re: Speaking of Sedar
|
1
|
Resverlogix Corp.
|
Mar 13, 2020 03:20PM
|
|
Re: Remembering Relypsa
|
1
|
Resverlogix Corp.
|
Nov 30, 2018 12:20PM
|
